Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam® (Cholic Acid)

Next Previous
Trial Profile

A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam® (Cholic Acid)

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cholic acid (Primary)
  • Indications Inborn genetic disorders; Infantile Refsum disease; Peroxisomal disorders; Zellweger syndrome
  • Focus Adverse reactions
  • Acronyms REPLACE Registry
  • Sponsors Mirum Pharmaceuticals; Travere Therapeutics

Most Recent Events

  • 06 Feb 2023 Status changed from recruiting to active, no longer recruiting.
  • 07 Dec 2020 Planned number of patients changed from 110 to 55.
  • 29 Jun 2020 Planned End Date changed from 1 Aug 2030 to 1 Jul 2039.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top